Atlas Trials

Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers

Clinical trial NCT05834426 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05834426
Sponsor
Sociedad de Lucha Contra el Cáncer del Ecuador
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Lymphoma, B-CellNeoplasmsCancerHigh-grade B-cell LymphomaDiffuse Large B Cell LymphomaNon Hodgkin LymphomaMetabolomics
Start date
2023-09-01
Primary completion
2026-08-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.